Print

GenMark Diagnostics (GNMK) Enters into License Agreement with PerkinElmer, Inc. (PKI) for Microfluidics Patent Portfolio  
3/29/2012 6:59:44 AM

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (NASDAQ: GNMK), announced today that it has entered into a license agreement with PerkinElmer, granting GenMark a non-exclusive license under PerkinElmer’s microfluidics patent portfolio.
//-->